Glutamine Role in Preventing Vaso-occlusive Crisis Among SCD Patients
Status:
Recruiting
Trial end date:
2023-08-04
Target enrollment:
Participant gender:
Summary
Prospective phase IV interventional open label randomized controlled trial to assess safety
and efficacy of glutamine in preventing vaso-occlusive crisis (VOC) episodes in sickle cell
pediatrics and adolescents' patients